-5%
Highnoon Labs
Genthro 500mg Tablets 6s
20 Tablets
Rated 4.5 out of 5 (49)
Rs. 1,275Rs. 1,340
In Stock
-5%
Pfizer
Clotnil Tablets 75mg 10s
Rated 4.0 out of 5 (14)SKU HP-04265
A tablet containing Clopidogrel, indicated for Stroke.
Rs. 795Rs. 835-5%
You save Rs. 40
1 Device
In StockSet your city for an exact delivery date
In stock at selected branches
Quantity
Clotnil Tablets 75mg 10s quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 795
What it is used for: Stroke.
Indications as listed by the manufacturer: Secondary prevention of atherothrombotic events : Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or establishedperipheral arterial disease. Prevention of atherothrombotic and thromboembolic events in atrial fibrillation: In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.
How it works: Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation. The active metabolite of clopidogrel selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet P2Y12 receptor and the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex, thereby inhibiting platelet aggregation. Due to the irreversible binding, platelets exposed are affected for the remainder of their lifespan (approximately 7-10 days) and recovery of normal platelet function occurs at a rate consistent with platelet turnover. Platelet aggregation induced by agonists other than ADP is also inhibited by blocking the amplification of platelet activation by released ADP.
Active ingredient: Clopidogrel.
Reported side effects: Abdominal pain, dyspepsia, gastritis, diarrhea, nausea, vomiting, constipation, gastrointestinal hemorrhage, ulceration, neutropenia, rash, palpitation, syncope, drowsiness, asthenia, neuralgia, paresthesia and vertigo.
Known drug interactions: Warfarin , Glycoprotein IIb/IIIa inhibitors , Acetylsalicylic acid (ASA) , Heparin , Thrombolytics , NSAIDs , SSRIs , omeprazole and esomeprazole, fluvoxamine, fluoxetine, moclobemide, voriconazole, fluconazole, ticlopidine, carbamazepine, and efavirenz .
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Adults : 75mg daily with or without food. Non-ST segment elevation acute coronary syndrome : Adults - 300mg loading dose followed by 75mg daily given in combination with 75-100mg aspirin daily. Children : Not recommended. Always consult your doctor or pharmacist for dose adjustments.
Active ingredient: Clopidogrel. Labelled strength: 75mg.
- 1.Hypersensitivity to the active substance. 2. Active pathological bleeding such as peptic ulcer or intracranial haemorrhage. 3.Severe hepatic impairment.
- Acquired haemophilia: in cases of confirmed isolated activated Partial Thromboplastin Time (aPTT) prolongation with or without bleeding, acquired haemophilia should be considered. Patients with a confirmed diagnosis, clopidogrel should be discontinued.
- Recent ischaemic stroke: Clopidogrel cannot be recommended during the first 7 days after acute ischaemic stroke .
- Hepatic impairment: Experience is limited in patients with moderate hepatic disease who may have bleeding diatheses. Clopidogrel should therefore be used with caution in this population .
- Due to the risk of bleeding and haematological adverse reactions, blood cell count determination and/or other appropriate testing should be promptly considered whenever clinical symptoms suggestive of bleeding arise during the course of treatment. Patients should be followed carefully for any signs of bleeding including occult bleeding, especially during the first weeks of treatment and/or after invasive cardiac procedures or surgery.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Clotnil Pharmaceuticals (Pvt) Ltd.. Country of origin: United Kingdom.
4.0
Rated 4.0 out of 514 verified ratings
- 5★0%
- 4★50%
- 3★50%
- 2★0%
- 1★0%
- Rabia N.4 Aug 2026Rated 4.0 out of 5
Effective, but it took closer to two months than the four weeks I was hoping for.
- Usman TariqVerified Purchase27 Jul 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Adnan YousufVerified Purchase17 Jul 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Mehwish A.Verified Purchase23 Jun 2026Rated 4.0 out of 5
No issues with the item itself. I would have liked a cold pack for the summer heat.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Stroke.
Indications as listed by the manufacturer: Secondary prevention of atherothrombotic events : Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or establishedperipheral arterial disease. Prevention of atherothrombotic and thromboembolic events in atrial fibrillation: In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.
How it works: Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation. The active metabolite of clopidogrel selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet P2Y12 receptor and the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex, thereby inhibiting platelet aggregation. Due to the irreversible binding, platelets exposed are affected for the remainder of their lifespan (approximately 7-10 days) and recovery of normal platelet function occurs at a rate consistent with platelet turnover. Platelet aggregation induced by agonists other than ADP is also inhibited by blocking the amplification of platelet activation by released ADP.
Active ingredient: Clopidogrel.
Reported side effects: Abdominal pain, dyspepsia, gastritis, diarrhea, nausea, vomiting, constipation, gastrointestinal hemorrhage, ulceration, neutropenia, rash, palpitation, syncope, drowsiness, asthenia, neuralgia, paresthesia and vertigo.
Known drug interactions: Warfarin , Glycoprotein IIb/IIIa inhibitors , Acetylsalicylic acid (ASA) , Heparin , Thrombolytics , NSAIDs , SSRIs , omeprazole and esomeprazole, fluvoxamine, fluoxetine, moclobemide, voriconazole, fluconazole, ticlopidine, carbamazepine, and efavirenz .
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Adults : 75mg daily with or without food. Non-ST segment elevation acute coronary syndrome : Adults - 300mg loading dose followed by 75mg daily given in combination with 75-100mg aspirin daily. Children : Not recommended. Always consult your doctor or pharmacist for dose adjustments.
Active ingredient: Clopidogrel. Labelled strength: 75mg.
- 1.Hypersensitivity to the active substance. 2. Active pathological bleeding such as peptic ulcer or intracranial haemorrhage. 3.Severe hepatic impairment.
- Acquired haemophilia: in cases of confirmed isolated activated Partial Thromboplastin Time (aPTT) prolongation with or without bleeding, acquired haemophilia should be considered. Patients with a confirmed diagnosis, clopidogrel should be discontinued.
- Recent ischaemic stroke: Clopidogrel cannot be recommended during the first 7 days after acute ischaemic stroke .
- Hepatic impairment: Experience is limited in patients with moderate hepatic disease who may have bleeding diatheses. Clopidogrel should therefore be used with caution in this population .
- Due to the risk of bleeding and haematological adverse reactions, blood cell count determination and/or other appropriate testing should be promptly considered whenever clinical symptoms suggestive of bleeding arise during the course of treatment. Patients should be followed carefully for any signs of bleeding including occult bleeding, especially during the first weeks of treatment and/or after invasive cardiac procedures or surgery.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Clotnil Pharmaceuticals (Pvt) Ltd.. Country of origin: United Kingdom.
4.0
Rated 4.0 out of 514 verified ratings
- 5★0%
- 4★50%
- 3★50%
- 2★0%
- 1★0%
- Rabia N.4 Aug 2026Rated 4.0 out of 5
Effective, but it took closer to two months than the four weeks I was hoping for.
- Usman TariqVerified Purchase27 Jul 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Adnan YousufVerified Purchase17 Jul 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Mehwish A.Verified Purchase23 Jun 2026Rated 4.0 out of 5
No issues with the item itself. I would have liked a cold pack for the summer heat.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
PfizerClotnil Tablets 75mg 10sRs. 795Rated 4.0 out of 5
StandpharmXiga 5mg Tablets 14sRs. 1,595Rated 4.5 out of 5
Martin DowAldactone Tablets 100mg 10sRs. 1,390Rated 4.5 out of 5
Bundle total
Rs. 3,780Rs. 4,065
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in Medicine
